Not applicableStudy completedNCT01248988What this trial is testingPost Marketing Surveillance of Synflorix Vaccine Safety Among Infants in KoreaWho this might be right forInfections, Streptococcal GlaxoSmithKline 622
Post-approval studies (Phase 4)Study completedNCT00239694What this trial is testingPPV: Pneumococcal Polysaccharide Vaccine in Older AdultsWho this might be right forAging National Institute on Aging (NIA) 100
Early research (Phase 1)Study completedNCT02719379What this trial is testingImmune Response to Pneumococcal Polysaccharide Vaccine (23-valent) Predicts Asthma Status and Outcomes in Late Adolescents With AsthmaWho this might be right forAsthma Rohit Divekar 60
Large-scale testing (Phase 3)Study completedNCT00562354What this trial is testingStudy Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Adults Aged >= 50 YearsWho this might be right forHealthy Pfizer 271
Large-scale testing (Phase 3)Study completedNCT00586612What this trial is testingPrimary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm InfantsWho this might be right forHaemophilus Influenzae Type bNeisseria Meningitidis GlaxoSmithKline 313
Large-scale testing (Phase 3)Study completedNCT01444781What this trial is testingStudy of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy InfantsWho this might be right forDiphtheriaTetanusWhooping Cough+2 more Sanofi Pasteur, a Sanofi Company 1,106
Large-scale testing (Phase 3)Study completedNCT03439657What this trial is testingImmunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and OlderWho this might be right forHerpes Zoster GlaxoSmithKline 913
Testing effectiveness (Phase 2)Study completedNCT00219401What this trial is testingNeonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New GuineaWho this might be right forPneumoniaMeningitisOtitis Media Papua New Guinea Institute of Medical Research 318
Post-approval studies (Phase 4)Study completedNCT05731115What this trial is testingLot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide VaccineWho this might be right forPneumococcal Infections Sinovac Biotech Co., Ltd 1,800
Testing effectiveness (Phase 2)Study completedNCT04168190What this trial is testingA Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001)Who this might be right forPneumonia, Pneumococcal Merck Sharp & Dohme LLC 600
Not applicableStudy completedNCT02535546What this trial is testingSeasonal Trends in Pneumococcal Carriage in COPD PatientsWho this might be right forChronic Obstructive Pulmonary Disease (COPD) Beaumont Hospital 150
Not applicableUnknownNCT05578144What this trial is testingUsing "SDM With PDAs" to Help Infant Family to Decide the Third Primary Dosing Pneumococcal Conjugate VaccineWho this might be right forInfants' Family Decide Baby's Vaccine Taipei Medical University Shuang Ho Hospital 180
Early research (Phase 1)Study completedNCT00756067What this trial is testingEvaluation of Pneumococcal Vaccine Formulations in ElderlyWho this might be right forInfections, Streptococcal GlaxoSmithKline 168
Post-approval studies (Phase 4)Looking for participantsNCT07242092What this trial is testingInfluence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDsWho this might be right forAutoimmune Rheumatic Diseases University of Sao Paulo General Hospital 192
Early research (Phase 1)UnknownNCT02544698What this trial is testingSafety Study of Pneumococcal 13-valent Conjugate Vaccine in Healthy People Aged 2 Months and OlderWho this might be right forPneumococcal 13-valent Conjugate Vaccine Beijing Chaoyang District Centre for Disease Control and Prevention 120
Not applicableStudy completedNCT01199016What this trial is testingEffect of Prevnar 13 on Ear Infections in ChildrenWho this might be right forOtitis Media Pfizer 239
Not applicableStudy completedNCT02610348What this trial is testingAnti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of AgeWho this might be right forHepatitis B Sanofi Pasteur, a Sanofi Company 122
Testing effectiveness (Phase 2)Study completedNCT03566940What this trial is testingAssess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization ScheduleWho this might be right forHealthy Janssen Vaccines & Prevention B.V. 302
Large-scale testing (Phase 3)Study completedNCT00688870What this trial is testingStudy Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in TaiwanWho this might be right forVaccinesPneumococcal Conjugate Vaccine Wyeth is now a wholly owned subsidiary of Pfizer 168
Not applicableNot Yet RecruitingNCT07659470What this trial is testingRANDOMIZED CONTROLLED TRIAL OF TEXT MESSAGE TO INCREASE PNEUMOCOCCAL VACCINATION IN ADULTS IN CHILE.Who this might be right forPneumococcal InfectionsImmunization ProgramsVaccination Coverage+4 more Pablo Tomás Valenzuela García 43,000